title: Grading of severe follicular rash in patients receiving EGFR inhibitors.
authors.forename: Ausilia Maria
authors.initials: AM
authors.lastname: Manganoni
authors.forename: Camillo
authors.initials: C
authors.lastname: Farisoglio
authors.forename: Vittorio
authors.initials: V
authors.lastname: Ferrari
authors.forename: Alberto
authors.initials: A
authors.lastname: Zaniboni
authors.forename: Giordano
authors.initials: G
authors.lastname: Beretta
authors.forename: Fausto
authors.initials: F
authors.lastname: Meriggi
authors.forename: Piergiacomo
authors.initials: P
authors.lastname: Calzavara-Pinton
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects*; D003875:Drug Eruptions / Q000145:classification*; D066246:ErbB Receptors / Q000037:antagonists & inhibitors*; D005499:Folliculitis / Q000139:chemically induced* / Q000145:classification*; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy*
chemical_list: D000970:Antineoplastic Agents; C512478:EGFR protein, human; D066246:ErbB Receptors